News Author: Patrice Wendling Publish date: June 23, 2015
The aromatase inhibitor letrozole was associated with roughly a 42% increase in the pregnancy rate, compared with clomiphene citrate in infertile wome...
News Author: Patrice Wendling Publish date: June 17, 2015
The rate of ectopic pregnancy following conception with assisted reproductive technology has declined from 20 to 12 cases per thousand in a nationwide...
News Author: Patrice Wendling Publish date: June 17, 2015
Conception through assisted reproductive technology is not associated with lower academic performance in adolescence, according to a Danish national c...
News Author: Patrice Wendling Publish date: June 17, 2015
Key clinical point: Conception by assisted reproductive technology is not associated with poorer academic performance in adolescence.
Major findin...
News Author: Patrice Wendling Publish date: June 14, 2015
Key clinical point: Inotuzumab ozagamicin shows promise as a new treatment option for relapsed or refractory acute lymphoblastic leukemia.
Major f...
News Author: Patrice Wendling Publish date: June 14, 2015
Key clinical point: Dasatinib provides more molecular responses than imatinib, but no survival advantage at 2 years in the first-line treatment of...
News Author: Patrice Wendling Publish date: June 12, 2015
Key clinical point: Venetoclax plus rituximab is a highly active nonchemotherapy combination for patients with relapsed or refractory chronic lymp...
News Author: Patrice Wendling Publish date: June 7, 2015
A new strategy that has been proposed with the aim of altering the disease course and slow progression of Crohn’s disease by reversing the treatment p...
News Author: Patrice Wendling Publish date: June 5, 2015
Key clinical point: The combination of paclitaxel plus trebananib may be useful in women with recurrent ovarian cancer and ascites.
Major finding:...
News Author: Patrice Wendling Publish date: June 4, 2015
Key clinical point: Researchers have identified an aggressive new histologic subset of metastatic castration-resistant prostate cancer.
Major find...
News Author: Patrice Wendling Publish date: June 3, 2015
Key clinical point: The percentage of patients achieving remission was lower in routine clinical practice with sofosbuvir-based regimens than in c...
News Author: Patrice Wendling Publish date: June 3, 2015
Key clinical point: The percentage of patients achieving remission was lower in routine clinical practice with sofosbuvir-based regimens than in c...
News Author: Patrice Wendling Publish date: June 3, 2015
News Author: Patrice Wendling Publish date: June 3, 2015
Key clinical point: Adding bevacizumab to standard carboplatin and paclitaxel chemotherapy significantly increases progression-free survival in ad...
News Author: Patrice Wendling Publish date: June 2, 2015
Key clinical point: Nivolumab provided superior overall survival vs. docetaxel and should be considered the new standard of care for previously tr...
